Showing results (391-400 of 2,995) with videos related to
Sort By:
Pageof 300
Clinical Kidney Journal|February 13, 2019
Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathyLida M Rodas, Ana Matas-García, Xoana Barros, et al.Clinical Kidney Journal|February 13, 2019
Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytesHernán Trimarchi, Romina Canzonieri, Cristian Costales-Collaguazo, et al.Clinical Kidney Journal|October 30, 2020
Survival of South African patients on renal replacement therapyThabiet Jardine, Esther Wong, Retha Steenkamp, et al.Clinical Kidney Journal|October 30, 2020
Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoingAlexandru Burlacu, Adrian CovicClinical Kidney Journal|October 30, 2020
Advocacy for renal replacement therapy: the role of renal registriesCecile Couchoud, Mohamed Benghanem GharbiClinical Kidney Journal|October 30, 2020
Ckj consolidation among Q1 Urology and Nephrology journalsAlberto OrtizClinical Kidney Journal|October 30, 2020
SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemiaBeatriz Fernandez-Fernandez, Pantelis Sarafidis, Mehmet Kanbay, et al.Clinical Kidney Journal|May 2, 2022
SARS-CoV-2 antibody dynamics among kidney transplant recipients 3 months after BNT162b2 vaccination: a prospective cohort studyDana Yelin, Benaya Rozen-Zvi, Dafna Yahav, et al.Clinical Kidney Journal|May 2, 2022
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney diseaseJavier Naranjo, Mónica Furlano, Ferran Torres, et al.Clinical Kidney Journal|May 2, 2022
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathyFrancesco P Schena, Giovanni Tripepi, Michele Rossini, et al.Pageof 300